Selinexor: A first-in-class SINE compound for treatment of relapsed refractory multiple myeloma

Shambavi Richard, Joshua Richter, Sundar Jagannath

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Selinexor: A first-in-class SINE compound for treatment of relapsed refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences